COMMUNIQUÉS West-GlobeNewswire

Novavax Initiates Phase 1/2 Trial of NanoFlu(TM) Vaccine in Older Adults

19/09/2017 - 15:05

Recently published NanoFlu(TM) preclinical data provide strong rationale for Phase 1/2 clinical trial based on robust antibody titers and improved protective responses against both current and drifted strains Data from [...]

Unlimited SharePoint migration, a real game changer for IT pros! Jump to Office 365!

19/09/2017 - 14:03

Cloudiway is known for its SaaS migration platform - apps.cloudiway.com - a smart tool, powerful and user-friendly to fully automate migration processes and easily move data, contents and users to the cloud. The growing [...]

Verona Pharma plc : Miscellaneous

19/09/2017 - 13:46

Issue of Shares September 19, 2017, London - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

ProMIS Neurosciences Announces Successful Humanization of Lead Product Candidate PMN310 for Alzheimer's Disease

19/09/2017 - 13:30

Clinical trials evaluating PMN310 expected to initiate in 2019 TORONTO and CAMBRIDGE, Mass. - September 19, 2017 - ProMIS Neurosciences, Inc., a company focused on discovery and development of precision treatments for [...]

MPI - LiPlaCis Phase 2 Recruitment Ongoing in DRP Screened Breast Cancer Patients: Relevant Clinical Benefits in 3 out of 5 Treated Patients

19/09/2017 - 12:45

Hoersholm, Denmark, September 19, 2017 - Medical Prognosis Institute A/S ("MPI") today announced early data from Oncology Ventures (a spinout from MPI) ongoing LiPlaCis® Phase 1/2 study show response and clinical [...]

Dangote Foundation, GBCHealth, join forces to build Coalition on Health

19/09/2017 - 11:52

NEW YORK, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Dangote Foundation ( www.Dangote.com ) and GBCHealth have joined forces to forge a new model of partnership, African Business Coalition on Health (GBCHealth) in Africa. [...]

Glycotope outlicenses GlycoExpress® Cell Line to Airway Therapeutics

19/09/2017 - 10:30

Glycotope outlicenses GlycoExpress® Cell Line to Airway Therapeutics Berlin, Germany, 19 September 2017 - Glycotope GmbH [Glycotope], a clinical-stage immuno-oncology company built on world-leading glyco-biology [...]

FIT Biotech: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

19/09/2017 - 09:00

FIT Biotech Oy Company release September 19, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

TiGenix Business and Financial Update for the First Half 2017

19/09/2017 - 07:00

PRESS RELEASE Regulated information TiGenix Business and Financial Update for the First Half 2017 (Conference call and webcast today at 15:00 CET) Leuven (BELGIUM) - September 19, 2017, 07:00h CET - TiGenix NV (Euronext [...]

Rapport d'activité et rapport financier de TiGenix pour le premier semestre de 2017

19/09/2017 - 07:00

COMMUNIQUÉ DE PRESSE INFORMATIONS RÈGLEMENTÉES Rapport d'activité et rapport financier de TiGenix pour le premier semestre de 2017 (Conférence téléphonique et webdiffusion aujourd'hui à 15h CET) Louvain (BELGIQUE) - 19 [...]

Summit Therapeutics Announces Closing of its ADS Public Offering Raising USD20.1M Before Expenses

18/09/2017 - 19:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Summit Therapeutics plc (" [...]

Sanofi : Disclosure of trading in own shares

18/09/2017 - 18:00

Reporting EN This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, [...]

Sanofi : Déclaration des transactions sur actions propres

18/09/2017 - 18:00

Reporting FR This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, [...]

Ossur Hf : Transactions in relation to share buyback program

18/09/2017 - 18:00

Announcement from Össur hf. No. 67/2017 Reykjavík, 18 September 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Novo Nordisk A/S - Share repurchase programme

18/09/2017 - 15:40

Bagsværd, Denmark, 18 September 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Medtronic Announces FDA Approval and U.S. Launch of Next Generation Spinal Cord Stimulator for Chronic Pain Management

18/09/2017 - 15:00

The Intellis Platform Includes the World's Smallest Implantable Spinal Cord Stimulator and Offers Personalized Pain Relief and Advanced Activity Tracking DUBLIN - September 18, 2017 - Medtronic plc (NYSE:MDT) today [...]

AroCell AB: New application for AroCell TK 210 ELISA opens new opportunities for drug development research

18/09/2017 - 14:15

Uppsala September 18, 2017 PRESS RELEASE New application for AroCell TK 210 ELISA opens new opportunities for drug development research AroCell AB (publ) announces today that an abstract submitted by Kiran Kumar [...]

Prothena Presents New Research Supporting Clinical Relevance of Cardiac Biomarker NT-proBNP in AL Amyloidosis

18/09/2017 - 14:00

Preclinical Research Demonstrating a Direct Relationship Between Misfolded Light Chain Toxicity and NT-proBNP Production Clinical Outcomes Research Showing a Correlation between NT-proBNP Response and Health-related [...]

Advanced Bifurcation Systems to Sponsor XIII European Bifurcation Club Meeting

18/09/2017 - 13:55

LOS ANGELES, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Advanced Bifurcation Systems ("ABS" or the "Company"), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations [...]